CXCR3 expression and activation of eosinophils: Role of IFN-γ-inducible protein-10 and monokine induced by IFN-γ

Journal of Immunology

Volumn 165, Issue 3, 2000, Pages 1548-1556

  Jinquan, Tan ^a,c   Jing, Chen ^a,c   Jacobi, Henrik H ^a   Reimert, Claus M ^a   Millner, Anders ^a   Quan, Sha ^a   Hansen, Jens B ^a   Dissing, Steen ^b   Malling, Hans Jørgen ^a   Skov, Per S ^a   Poulsen, Lars K ^a  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 2; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM CELL LEVEL; CHEMOTAXIS; CONTROLLED STUDY; EOSINOPHILIA; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 0034254203     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.3.1548     Document Type: Article

References (50)

1. Weng, Y., S. J. Siciliano, K. E. Waldburger, A. Sirolina-Meisher, M. J. Staruch, B. L. Daugherty, S. L. Gould, M. S. Springer, and J. A. DeMartino. 1998. Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors. J. Biol. Chem. 273:18288.
2. Soto, H., W. Wang, R. M. Strieter, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, J. Hedrick, and A. Zlotnik. 1998. The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3. Proc. Natl. Acad. Sci. USA 95:8205.
3. Cole, K. E., C. A. Strick, T. J. Paradis, K. T. Ogborne, M. Loetscher, R. P. Gladue, W. Lin, J. G. Boyd, B. Moser, D. E. Wood, et al. 1998. Interferon-inducible T cell α chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J. Exp. Med. 187:2009.
4. Piali, L., C. Weber, G. LaRosa, C. R. Mackay, T. A. Springer, I. Clark-Lewis, and B. Moser. 1998. The chemokine receptor CXCR3 mediates rapid and shear-resistant adhesion-induction of effector T lymphocytes by the chemokines IP10 and Mig. Eur. J. Immunol. 28:961.
5. Sallusto, F., D. Lenig, C. R. Mackay, and Lanzavecchia. A. 1998. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 187:875.
6. Qin, S., J. B. Rottman, P. Myers, N. Kassam, M. Weinblatt, M. Loetscher, A. E. Koch, B. Moser, and C. R. Mackay. 1998. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Infest. 101:746.
7. Sgadari, C., J. M. Farber, A. L. Angiolillo, F. Liao, J. Teruya-Feldstein, P. R. Burd, L. Yao, G. Gupta, C. Kanegane, and G. Tosato. 1997. Mig, the monokine induced by interferon-γ, promotes tumor necrosis in vivo. Blood 89: 2635.
8. Hansel T. T., J. J. De-Vries, T. Iff, S. Rihs, M. Wandzilak, S. Betz, K. Blaser, and C. Walker. 1991. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils J. Immunol. Methods 12:105.
9. Jinquan, T., S. Quan, H. H. Jacobi, C. M. Reimert, A. Millner, J. B. Hansen, C. Thygesen, L. P. Ryder, H. O. Madsen, H.-J. Mailing, et al. 1999. Expression of the nuclear factors of activated T cells in eosinophils: regulation by IL-4 and IL-5. J. Immunol. 163:21.
10. + T lymphocyte migration. J. Immunol. 151:4545.
11. Jinquan, T., B. Deleuran, B. Gesser, H. Maar, M. Deleuran, C. G. Larsen, and K. Thestrup-Pedersen. 1995. Regulation of human T lymphocyte chemotaxis in vitro by T cell-derived cytokines IL-2, IFN-γ, IL-4, IL-10, and IL-13. J. Immunol. 154:3742.
12. Jinquan, T., J. Frydenberg, N. Mukaida, J. Bonde, C. G. Larsen, K. Matsushima, and K. Thestrup-Pedersen. 1995. Recombinant human growth regulated oncogene-α induces T lymphocyte chemotaxis: a process regulated via interleukin-8 receptors by IFN-γ, TNF-γ, IL-4, IL-10, and IL-13. J. Immunol. 155:5359.
13. Petering, H., O. Gotze, D. Kimmig, R. Smolarski, A., Kapp, and J. Elsner. 1999. The biologic role of interleukin-8: functional analysis and expression of CXCR1 and CXCR2 on human eosinophils. Blood 93:694.
14. Heid, C. A., J. Stevens, K. J. Livak, and P. M. William. 1996. Real time quantitative PCR. Genome Res. 6:986.
15. Kruse, N., M. Pette, K. Toyka, and P. Rieckmann. 1997. Quantification of cytokine mRNA expression by RT PCR in samples of previously frozen blood. J. Immunol. Methods 210:195.
16. 2+ transients in human coronary artery smooth muscle cells. Br. J. Pharmacol. 118: 1645.
17. Reimert C. M., P. S. Skov, and L. K. Poulsen. 1998. A microliter assay for activation of eosinophils: simultaneous monitoring of eosinophil adhesion and degranulation. Allergy 53:129.
18. Zigmond, S. H., and J. G. Hirsch. 1973. Leukocyte locomotion and chemotaxis: new methods for evaluation, and demonstration of a cell-derived chemotactic factor. J. Exp. Med. 137:387.
19. Rand, T. H., D. S. Silberstein, H. Kornfeld, and P. F. Weller. 1991. Human eosinophils express functional interleukin 2 receptors. J. Clin. Invest. 88:825.
20. Takanaski, S., R. Nonaka, Z. Xing, P. O'Byrne, J. Dolovich, and M. Jordana. 1994. Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils. J. Exp. Med. 180:711.
21. Ohkawara, Y., K. G. Lim, Z. Xing, M. Glibetic, K. Nakano, J. Dolovich, K. Croitoru, P. F. Weller, and M. Jordana. 1996. CD40 expression by human peripheral blood eosinophils. J. Clin. Invest. 97:1761.
22. Jinquan, T., S. Quan, G. Feili, C. G. Larsen, and K. Thestrup-Pedersen. 1999. Eotaxin activates T cells to chemotaxis and adhesion only if induced to express CCR3 by IL-2 together with IL-4. J. Immunol. 162:4285.
23. Williams, E. J., F. S. Walsh, and P. Doherty. 1994. Tyrosine kinase inhibitors can differentially inhibit integrin-dependent and CAM-stimulated neurite outgrowth. J. Cell Biol. 124:1029.
24. Matsumoto, H., and Y. Sasaki. 1989. Staurosporine, a protein kinase C inhibitor interferes with proliferation of arterial smooth muscle cells. Biochem. Biophys. Res. Commun. 158:105.
25. Chijiwa, T., A. Mishima, H. Hagiwara, M. Sano, K. Hayashi, T. Inoue, K. Naito, T. Toshioka, and H. Hidaka. 1990. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-(2-(ρ-bromocinnamylamino)ethyl)-5-isoquenilesulfonamide (H-89), of PC12D pheochromocytoma cells. J. Biol. Chem. 265:5267.
26. Sumi, T., and M. Ui. 1975. Potentiation of the adrenergic β-receptor-mediated insulin secretion in pertussis-sensitized rats. Endocrinology 97:352.
27. Blaya, C., J. Crespo, A. Crespo, and S. F. Alino. 1998. Effect of the protein kinase inhibitors, 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine H-7 and N-(2-[methylamino]ethyl)-5-isoquinoline-sulfonamide H-8 on Lewis lung carcinoma tumor progression. Eur. J. Pharmacol. 354:99.
28. Toullec, D., P. Pianetti, H. Coste, P. Bellevergue, T. Grand-Perret, M. Akajane, V. Baudet, P. Boissin, E. Boursier, and F. Loriolle. 1991. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266:15771.
29. Loetscher, M., P. Loetscher, N. Brass, E. Meese, and B. Moser. 1998. Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization. Eur. J. Immunol. 28:3696.
30. Jenh, C. H., M. A. Cox, H. Kaminski, M. Zhang, H. Byrnes, J. Fine, D. Lundell, C. C. Chou, S. K. Narula, and P. J. Zavodny. 1999. Species specificity of the CC chemokine 6Ckine signaling through the CXC chemokine receptor CXCR3: human 6Ckine is not a ligand for the human or mouse CXCR3 receptors. J. Immunol. 162:3765.
31. Bonecchi, R., G. Bianchi, P. P. Bordignon, D. D'Ambrosio, R. Lang, A. Borsatti, S. Sozzani, P. Allavena, P. A. Gray, A. Mantovani, et al. 1998. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 187:129.
32. Sorensen, T. L., M. Tani, J. Jensen, V. Pierce, C. Lucchinetti, V. A. Folcik, S. Qin, J. Rottman, F. Sellebjerg, R. M. Strieter, et al. 1999. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Invest. 103:807.
33. Sarris, A. H., D. Daliani, R. Ulmer, M. Crow, H. E. Broxmeyer, M. Reiss, N. Karasavvas, A. D. Zelenetz, W. Pugh, F. Cabanillas, et al. 1997. Interferon-inducible protein 10 as a possible factor in the pathogenesis of cutaneous T-cell lymphomas. Clin. Cancer Res. 3:169.
34. Farber, J. M. 1997. Mig and IP-10: CXC chemokines that target lymphocytes. J. Leukocyte Biol. 61:246.
35. Tai, P. C., C. J. Spry, C. Peterson, P. Venge, and I. Olsson 1984. Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein. Nature 309:182.
36. Young, J. D., C. G. Peterson, P. Venge, and Z. A. Cohn. 1986. Mechanism of membrane damage mediated by human eosinophil cationic protein. Nature 321: 613.
37. Rosenberg, H. F., and H. L. Tiffany. 1994. Characterization of the eosinophil granule proteins recognized by the activation-specific antibody EG2. J. Leukocyte Biol. 56:502.
38. Gibson, P. G., K. L. Woolley, K. Carty, K. Murree-Allen, and N. Saltos. 1998. Induced sputum eosinophil cationic protein (ECP) measurement in asthma and chronic obstructive airway disease (COAD). Clin. Exp. Allergy 28:1081.
39. Rao, R., J. M. Frederick, I. Enander, R. K. Gregson, J. A. Warner, and J. O. Warner. 1996. Airway function correlates with circulating eosinophil, hut not mast cell, markers of inflammation in childhood asthma. Clin. Exp. Allergy 26:789.
40. Kasama, T., R. M. Strieter, N. W. Lukacs, M. D. Burdick, and S. L. Kunkel. 1994. Regulation of neutrophil-derived chemokine expression by IL-10. J. Immunol. 152:3559.
41. Hedrick, J. A., A. Helms, A. Vicari, and A. Zlotnik. 1998. Characterization of a novel CC chemokine, HCC-4, whose expression is increased by interleukin-10. Blood 91:4242.
42. Kodelja, V., C. Muller, O. Politz, N. Hakij, C. E. Orfanos, and S. Goerdt. 1998. Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1α with a Th2-associated expression pattern. J. Immunol. 160:1411.
43. Berkman, N., M. John, G. Roesems, P. J. Jose, P. J. Barnes, and K. F. Chung. 1995. Inhibition of macrophage inflammatory protein-1 a expression by IL-10: differential sensitivities in human blood monocytes and alveolar macrophages. J. Immunol. 155:4412.
44. Horton, M. R., M. D. Burdick, R. M. Strieter, C. Bao, and P. W. Noble. 1998. Regulation of hyaluronan-induced chemokine gene expression by IL-10 and IFN-γ in mouse macrophages. J. Immunol. 160:3023.
45. Ehrlich, L. C., S. Hu, W. S. Sheng, R. L. Sutton, G. L. Rockswold, P. K. Peterson, and C. C. Chao. 1998. Cytokine regulation of human microglial cell IL-8 production. J. Immunol. 160:1944.
46. Ito, S., P. Ansari, M. Sakatsume, H. Dickensheets, N. Vazquez, R. P. Donnelly, A. C. Larner, and D. S. Finbloom, 1999. Interleukin-10 inhibits expression of both interferon α-and interferon γ-induced genes by suppressing tyrosine phosphorylation of STAT1. Blood 93:1456.
47. Tebo, J. M. H. S. Kim, J. Gao, D. A. Armstrong, and T. A. Hamilton. 1998. Interleukin-10 suppresses IP-10 gene transcription by inhibiting the production of class I interferon. Blood 92:4742.
48. Sozzani, S., S. Ghezzi, G. Iannolo, W. Luini, A. Borsatti, N. Polentarutti, A. Sica, M. Locati, C. Mackay, T. N. Wells, et al. 1998. Interleukin 10 increases CCR5 expression and HIV infection in human monocytes. J. Exp. Med. 187:439.
49. Soto, H., W. Wang, R. M. Strieter, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, J. Hedrick, and A. Zlotnik. 1998. The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3. Proc. Natl. Acad. Sci. USA 95:8205.
50. Grimaldi, J. C., N. X. Yu, G. Grunig, B. W. Seymour, F. Cottrez, D. S. Robinson, N. Hosken, W. G. Ferlin, X. Wu, H. Soto, et al. 1999. Depletion of eosinophils in mice through the use of antibodies specific for C-C chemokine receptor 3 (CCR3). J. Leukocyte Biol. 65:846.